Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Endoscopic Management According To Standard Of Care

Research Leaders

5 sponsors active, led by Helwan University

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 2 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

50%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Completed2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (2)

Showing 2 of 2 trials
NCT04370145Phase 4CompletedPrimary

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

NCT04385147CompletedPrimary

Advanced Endoscopy During COVID-19

Showing all 2 trials

Research Network

Common Treatments

  • Endoscopic Management According To Standard Of Care1
  • Tinidazole1

Active Sponsors

  • Helwan University1
  • National Liver Institute, Egypt1
  • Shanghai Children's Hospital1
  • Tongji Hospital1
  • Al-Azhar University1

Top Investigators

Related Conditions

  • Obstructive Jaundice1
  • Pancreas Cancer1
  • Cholangiocarcinoma1
  • Antibodies Drug Specific1
  • Covid191

Activity Timeline